การพัฒนาและประเมินชุดสิทธิประโยชน์ (ที่ไม่ใช่ยา) เพื่อสนับสนุนการเข้าถึงบริการสุขภาพของประเทศไทย เป็นการดําเนินงานที่เป็

Background As universal health coverage schemes mature, governments often seek to improve patient choice, whilst ensuring that services are appropriate, high-quality, and financially sustainable, especially for high-cost interventions like dialysis. Policy levers to manage supply and demand for ser

66203067RM019L0Monitoring and evaluation of high cost medicines,National List of Essential Medicines,Thailand

66183067HM017L0health economic evaluation,health technology assessment,medical innovation,research and development,target product profiles

The Health Intervention and Technology Assessment Program Foundation (HITAP) establishes the Global Research Unit (GRU), a new team created to strengthen evidence-informed policymaking in Thailand and internationally. Why GRU Matters Health technology assessment (HTA) h

The mental health disorders concluded mental, neurological and substance use (MNS) disorders, which are highly prevalent and burdensome worldwide. The resources that have been provided to tackle the huge burden of MNS disorders are insufficient, inequitably distributed, and inefficiently used, which leads to a treatment gap of more than 75% in many

COVID-19 has shown that irresepctive of national borders, the infectious disease brings multi-dimensional challenges requiring concerted global and regional efforts to address it. In contrast to the European Union and the African Union, the Association of Southeast Asian Nations (ASEAN), the regional cooperation body in Southeast Asia, has had no e

โรคติดเชื้อ Human Papillomavirus (HPV) เป็นโรคติดต่อทางเพศสัมพันธ์ที่พบได้บ่อยและสามารถแพร่กระจายได้ง่ายเพียงการสัมผัสทางผิวหนัง (skin-to-skin contact